Search
for
Sort by
Research
420-450 / 1000+ results![Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies](/images/research/ca05f038-a9c5-47cf-bbb8-ae30df61a42d/small/20160.jpg)
research Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.
research Dietary patterns, plasma and hair trace element in Ukrainian cohort of adults during COVID-19 pandemic: a cross-sectional study
Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.
research Epidemiological profile of patients presenting to dermatology department of a tertiary care hospital during nationwide lockdown due to COVID-19: a retrospective study from north India
research Raw data from JAAD research letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
research Recomendaciones Rama de Dermatología Pediátrica, Sociedad Chilena de Pediatría. Pandemia COVID-19
The document's conclusion cannot be provided because the document itself is not accessible or cannot be parsed.
![Cutaneous signs in <scp>COVID</scp> ‐19 patients: A review](/images/research/18589255-bfad-4ae4-a89d-eb0cb10cbeaa/small/17463.jpg)
research Cutaneous signs in COVID ‐19 patients: A review
COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.
![Cutaneous manifestations and considerations in <scp>COVID</scp> ‐19 pandemic: A systematic review](/images/research/d61f62de-e9c9-48a8-a861-e03ad91b8517/small/34485.jpg)
research Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.
![<scp>COVID</scp> ‐19 induced telogen effluvium](/images/research/5394369c-b7d0-4677-9569-19f56c411dd6/small/17088.jpg)
research COVID ‐19 induced telogen effluvium
COVID-19 may cause temporary hair loss in some people.
![Characteristics of hair loss after <scp>COVID</scp>‐19: A systematic scoping review](/images/research/202e463d-4245-4fdf-a7b0-3743eeb8aa6e/small/23673.jpg)
research Characteristics of hair loss after COVID ‐19: A systematic scoping review
COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.
![Covid induced telogen effluvium (CITE): An insight](/images/research/f01f1f86-ef2d-4f04-8211-0cf75dd9b892/small/23749.jpg)
research Covid induced telogen effluvium (CITE): An insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
![The effect of <scp>COVID</scp>‐19 on development of hair and nail disorders: a Turkish multicenter, controlled study](/images/research/1cc3944c-cc6c-4650-8e83-5ba751a72c82/small/16839.jpg)
research The effect of COVID ‐19 on development of hair and nail disorders: a Turkish multicenter, controlled study
COVID-19 can cause hair and nail disorders after infection.
![Ultrastructural evidence for anagen hair follicle infection with <scp>SARS‐CoV</scp>‐2 in early‐onset <scp>COVID</scp>‐19 effluvium](/images/research/c9e1515b-99c5-4f06-8cc9-c5f239ebb82f/small/23683.jpg)
research Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV ‐2 in early‐onset COVID ‐19 effluvium
COVID-19 may cause early hair loss by infecting hair follicles.
![New‐onset and exacerbated skin diseases after <scp>COVID</scp>‐19 infection: A systematic review](/images/research/a29282d7-afdc-40c9-9536-1ef23f1fdcc3/small/16917.jpg)
research New‐onset and exacerbated skin diseases after COVID ‐19 infection: A systematic review
COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.
![Intermittent chronic telogen effluvium with an unusual dermoscopic finding following <scp>COVID</scp> ‐19](/images/research/38978f8f-0ee8-40c0-9f7d-38eb04c6d1cf/small/13008.jpg)
research Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.
research Dermatologic Changes in Experimental Model of Long COVID
Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.
![Post-COVID Telogen Effluvium.](/images/research/ea3a4cd3-19f5-40ed-b426-ae05f751bb4b/small/23618.jpg)
research Post-COVID Telogen Effluvium.
COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.
![Skin amidst <scp>COVID</scp> ‐19 pandemic](/images/research/ecea8a80-413f-43d4-8f2a-8b697ca58c20/small/17423.jpg)
research Skin amidst COVID ‐19 pandemic
COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.
![Scalp capillarectasia as a trichoscopic sign of <scp>COVID</scp>‐19‐associated telogen effluvium](/images/research/295d07b2-7ef0-4842-b189-002411aa915f/small/23582.jpg)
research Scalp capillarectasia as a trichoscopic sign of COVID ‐19‐associated telogen effluvium
Dilated scalp capillaries might be a sign of hair loss related to COVID-19.
![Pediatric alopecia areata following <scp>COVID</scp>‐19 infection](/images/research/ff85d080-8fa9-42d1-b04c-57b8eb98df74/small/23593.jpg)
research Pediatric alopecia areata following COVID ‐19 infection
Some children may develop hair loss after having COVID-19.
![Eflúvio telogeno pós-COVID](/images/research/52c73286-4f17-4754-90a2-c8a5495c548b/small/23685.jpg)
research Eflúvio telogeno pós-COVID
COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.
![A Case of Telogen Effluvium as COVID Sequelae](/images/research/f4086ff4-2e9d-4990-be44-a7dcc45cfd1f/small/23695.jpg)
research A Case of Telogen Effluvium as COVID Sequelae
A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.
![Eflúvio Telógeno pós-COVID: uma revisão integrativa](/images/research/25601502-d6c3-4d3e-8a9c-5ec7de338940/small/23587.jpg)
research Eflúvio Telógeno pós-COVID: uma revisão integrativa
COVID-19 can cause temporary hair loss.
![Change of the diagnostic distribution in applicants to dermatology after <scp>COVID</scp> ‐19 pandemic: What it whispers to us?](/images/research/e1229a42-a998-47ed-97d3-4fcf1cdfac38/small/20853.jpg)
research Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.
![The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome](/images/research/3825bafd-be6c-4125-9336-aec702b3d432/small/20797.jpg)
research The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.
![Analysis of post-COVID symptoms and predisposing factors for chronic post-COVID syndrome](/images/research/3994bed7-003a-459e-bce4-178cffe6f41b/small/36792.jpg)
research Analysis of post-COVID symptoms and predisposing factors for chronic post-COVID syndrome
Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.
![The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit](/images/research/0c4c012a-ceee-4faa-986a-465f5fb54fb7/small/23631.jpg)
research The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit
Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.
![070 Bacillary Load and Reactional States in Leprosy - A Surge in Severity the COVID Era?](/images/research/0d8c9515-0f46-4acd-993c-fa407734a277/small/17101.jpg)
research 070 Bacillary Load and Reactional States in Leprosy - A Surge in Severity the COVID Era?
The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.
![Androgenetic alopecia and <scp>COVID</scp> ‐19: A review of the hypothetical role of androgens](/images/research/337a82e8-082b-4fd9-8d20-46a90dc515ff/small/5236.jpg)
research Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens
Possible link between androgens and COVID-19 severity; more research needed.
![Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study](/images/research/e56861ff-7a38-4323-b9ce-ddce9386194b/small/35475.jpg)
research Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.